243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK

Annals of Oncology ◽

10.1016/j.annonc.2021.08.526 ◽

2021 ◽

Vol 32 ◽

pp. S465

Author(s):

M.M. Fouda ◽

V. Kuriakose

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Comparative Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Clinical Impact ◽

Breast Cancer Patients ◽

The Uk

Download Full-text

CLINICAL IMPACT OF BREAST CANCER STEM CELLS IN METASTATIC BREAST CANCER PATIENTS

The Breast ◽

10.1016/s0960-9776(19)30667-8 ◽

2019 ◽

Vol 48 ◽

pp. S42-S43

Author(s):

Mohamed Elbaiomy ◽

Tamer Akl ◽

Ahmed Elsayeid

Keyword(s):

Breast Cancer ◽

Stem Cells ◽

Metastatic Breast Cancer ◽

Cancer Stem Cells ◽

Cancer Patients ◽

Metastatic Breast ◽

Clinical Impact ◽

Breast Cancer Stem Cells ◽

Breast Cancer Patients

Download Full-text

PO54 A RETROSPECTIVE MULTICENTER OBSERVATION STUDY IN METASTATIC BREAST CANCER PATIENTS: COMPARATIVE ANALYSIS ON EFFICACY OF ERIBULIN MESYLATE WITH TAXANE REGIMENS (INCLUDING COMBINATION WITH BEVACIZUMAB)

The Breast ◽

10.1016/s0960-9776(15)30066-7 ◽

2015 ◽

Vol 24 ◽

pp. S40

Author(s):

Yasuko Kikuchi ◽

Kazuo Shirakawa ◽

Hajime Kanauchi ◽

Takako Wakeda ◽

Takayoshi Niwa ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Comparative Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Observation Study ◽

Eribulin Mesylate

Download Full-text

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-5027-0 ◽

2018 ◽

Vol 173 (3) ◽

pp. 521-532 ◽

Cited By ~ 11

Author(s):

Britt I. Drögemöller ◽

◽

Galen E. B. Wright ◽

Joanne Shih ◽

Jose G. Monzon ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Cancer Patients ◽

Decision Aid ◽

Metastatic Breast ◽

Treatment Decision ◽

Breast Cancer Patients ◽

Er Positive

Download Full-text

Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study

Scientific Reports ◽

10.1038/s41598-018-37472-z ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 1

Author(s):

Yizhao Xie ◽

Yannan Zhao ◽

Chengcheng Gong ◽

Zhanhong Chen ◽

Yinbin Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Retrospective Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients

Download Full-text

P1-08-21: Demographic and Clinical Characteristics of Metastatic Breast Cancer Patients and Biomarker-Based Prevalence in the UK, Germany, France, Spain and Italy (EU-5).

10.1158/0008-5472.sabcs11-p1-08-21 ◽

2011 ◽

Author(s):

A Ganguli ◽

M DeKoven ◽

V Bonthapally ◽

WC Lee ◽

S Ray

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Clinical Characteristics ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

The Uk

Download Full-text

1873 A retrospective multicenter observation study about comparative analysis on efficacy of eribulin mesylate with taxane regimens (including combination with bevacizumab) in metastatic breast cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(16)30823-1 ◽

2015 ◽

Vol 51 ◽

pp. S290 ◽

Cited By ~ 1

Author(s):

Y. Kikuchi ◽

K. Shirakawa ◽

H. Kanauchi ◽

T. Wakeda ◽

T. Niwa ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Comparative Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Observation Study ◽

Eribulin Mesylate

Download Full-text

Response evaluation with 18F-FDG PET/CT in metastatic breast cancer patients treated with Palbociclib: first experience in clinical practice

Annals of Nuclear Medicine ◽

10.1007/s12149-018-01323-8 ◽

2018 ◽

Vol 33 (3) ◽

pp. 193-200 ◽

Cited By ~ 3

Author(s):

Silvia Taralli ◽

Margherita Lorusso ◽

Valentina Scolozzi ◽

Valeria Masiello ◽

Fabio Marazzi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Cancer Patients ◽

Metastatic Breast ◽

Response Evaluation ◽

Breast Cancer Patients ◽

Pet Ct ◽

18F Fdg ◽

Fdg Pet Ct

Download Full-text

HSR21-051: Treatment Outcomes Among HR+/HER2- Advanced/Metastatic Breast Cancer Patients Receiving CDK 4 & 6 Inhibitors in a United States Clinical Practice Setting

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2020.7739 ◽

2021 ◽

Vol 19 (3.5) ◽

pp. HSR21-051

Author(s):

Yu-Jing Huang ◽

Paula D. Ryan ◽

Gregory L. Price ◽

Gebra Cuyun Carter ◽

Kristin M. Sheffield ◽

...

Keyword(s):

Breast Cancer ◽

United States ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Treatment Outcomes ◽

Cancer Patients ◽

Metastatic Breast ◽

Practice Setting ◽

Breast Cancer Patients ◽

Clinical Practice Setting

Download Full-text

Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?

Anti-Cancer Drugs ◽

10.1097/cad.0b013e32835679d3 ◽

2012 ◽

Vol 23 (10) ◽

pp. 1089-1098 ◽

Cited By ~ 6

Author(s):

Angela Esposito ◽

Elisabetta Munzone ◽

Vincenzo Bagnardi ◽

Laura Adamoli ◽

Angela Sciandivasci ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Cancer Patients ◽

Metastatic Breast ◽

Routine Clinical Practice ◽

Breast Cancer Patients

Download Full-text

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study

The Oncologist ◽

10.1634/theoncologist.2009-0029 ◽

2010 ◽

Vol 15 (8) ◽

pp. 799-809 ◽

Cited By ~ 75

Author(s):

Jean‐Marc Extra ◽

Eric C. Antoine ◽

Anne Vincent‐Salomon ◽

Thierry Delozier ◽

Pierre Kerbrat ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Cancer Patients ◽

Metastatic Breast ◽

Routine Clinical Practice ◽

Breast Cancer Patients

Download Full-text